(3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone

C67H114N12O14 — CID 140688044

IUPAC(3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
SMILESCC(C)C[C@@H]1NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H](C(C)C)OC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@H](C)C/C=C/c2ncccn2)N(C)C(=O)[C@H](C(C)C)N(C)C1=O
InChIInChI=1S/C67H114N12O14/c1-36(2)30-46-62(87)76(20)49(33-39(7)8)58(83)70-44(16)67(92)93-57(42(13)14)66(91)77(21)50(34-40(9)10)60(85)72-47(31-37(3)4)63(88)78(22)54(41(11)12)65(90)79(23)55(56(82)43(15)26-24-27-51-68-28-25-29-69-51)61(86)73-53(45(17)80)64(89)74(18)35-52(81)75(19)48(32-38(5)6)59(84)71-46/h24-25,27-29,36-50,53-57,80,82H,26,30-35H2,1-23H3,(H,70,83)(H,71,84)(H,72,85)(H,73,86)/b27-24+/t43-,44+,45-,46+,47+,48+,49+,50-,53+,54+,55+,56-,57-/m1/s1
InChIKeyVXQKIZKKFXABSN-CFSJXNOTSA-N
MW1311.72 g/mol
LogP3.28
Rot. Bonds18

About (3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone

(3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone (PubChem CID 140688044) has the molecular formula C67H114N12O14 and a molecular weight of 1311.72 g/mol. Its IUPAC name is (3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone.

Molecular Properties

Compound Name(3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
PubChem CID140688044
Molecular FormulaC67H114N12O14
Molecular Weight1311.72 g/mol
Exact Mass1310.86
IUPAC Name(3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
SMILESCC(C)C[C@@H]1NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H](C(C)C)OC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@H](C)C/C=C/c2ncccn2)N(C)C(=O)[C@H](C(C)C)N(C)C1=O
InChIInChI=1S/C67H114N12O14/c1-36(2)30-46-62(87)76(20)49(33-39(7)8)58(83)70-44(16)67(92)93-57(42(13)14)66(91)77(21)50(34-40(9)10)60(85)72-47(31-37(3)4)63(88)78(22)54(41(11)12)65(90)79(23)55(56(82)43(15)26-24-27-51-68-28-25-29-69-51)61(86)73-53(45(17)80)64(89)74(18)35-52(81)75(19)48(32-38(5)6)59(84)71-46/h24-25,27-29,36-50,53-57,80,82H,26,30-35H2,1-23H3,(H,70,83)(H,71,84)(H,72,85)(H,73,86)/b27-24+/t43-,44+,45-,46+,47+,48+,49+,50-,53+,54+,55+,56-,57-/m1/s1
InChIKeyVXQKIZKKFXABSN-CFSJXNOTSA-N
XLogP3.28
TPSA330.80 Ų
H-Bond Donors6
H-Bond Acceptors16
Rotatable Bonds18
Heavy Atoms93
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001311.72
LogP ≤ 53.28
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1016

Analyze (3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone?
The IUPAC name of (3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone (CID 140688044) is (3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone.
What is the SMILES notation for (3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone?
The canonical SMILES for (3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone is CC(C)C[C@@H]1NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H](C(C)C)OC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@H](C)C/C=C/c2ncccn2)N(C)C(=O)[C@H](C(C)C)N(C)C1=O.
What is the InChIKey of (3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone?
The InChIKey is VXQKIZKKFXABSN-CFSJXNOTSA-N. The full InChI is InChI=1S/C67H114N12O14/c1-36(2)30-46-62(87)76(20)49(33-39(7)8)58(83)70-44(16)67(92)93-57(42(13)14)66(91)77(21)50(34-40(9)10)60(85)72-47(31-37(3)4)63(88)78(22)54(41(11)12)65(90)79(23)55(56(82)43(15)26-24-27-51-68-28-25-29-69-51)61(86)73-53(45(17)80)64(89)74(18)35-52(81)75(19)48(32-38(5)6)59(84)71-46/h24-25,27-29,36-50,53-57,80,82H,26,30-35H2,1-23H3,(H,70,83)(H,71,84)(H,72,85)(H,73,86)/b27-24+/t43-,44+,45-,46+,47+,48+,49+,50-,53+,54+,55+,56-,57-/m1/s1.
What are the key properties of (3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone?
(3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone has a molecular weight of 1311.72 g/mol, XLogP of 3.28, 18 rotatable bonds, 6 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,6S,9S,12S,18S,21S,24S,27S,30R,33R)-18-[(1R)-1-hydroxyethyl]-21-[(E,1R,2R)-1-hydroxy-2-methyl-5-pyrimidin-2-ylpent-4-enyl]-3,7,13,16,22,25,31-heptamethyl-6,9,12,27,30-pentakis(2-methylpropyl)-24,33-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone is sourced from PubChem (CID 140688044), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).